Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, Prostate Cancer Treatment and Research, and Glioma Diagnosis and Treatment.
Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
A kinase-independent function of AKT promotes cancer cell survival
Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death